1 IBSAL, University of Salamanca, Salamanca, Spain.
2 National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Health Institute, Madrid, ES, Spain.
3 Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
4 Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center - IRCCS -, Rozzano (MI), Italy.
5 Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
6 Division of Cancer Sciences, University of Manchester, Manchester, UK.
7 Medical Oncology Unit, S. Orsola-Malpighi University Hospital, Bologna, Italy.
8 Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
9 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum-University of Bologna, Bologna, Italy.
10 Unit of Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
11 Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
12 Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
13 Research Insitute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
14 CIMA, University of Navarra, IdisNA, Navarra, Spain.
15 Coimbra Hospital and University Centre (CHUC), Coimbra, Portugal.
16 Università Politecnica delle Marche/Ospedali Riuniti di Ancona, Ancona, Italy.
17 Institute for Liver and Digestive Health, University College London, London, UK.
18 Biotech Research & Innovation Centre (BRIC), University of Copenhaghen, Copenhagen, Denmark.
19 La Sapienza University, Rome, Italy.
20 IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
21 UCL Cancer Institute, London, UK.
22 Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. chiara.braconi@glasgow.ac.uk.